Related references
Note: Only part of the references are listed.Biochemical Mechanisms Underlying Psychedelic-Induced Neuroplasticity
David E. Olson
BIOCHEMISTRY (2022)
Structure-based discovery of nonhallucinogenic psychedelic analogs
Dongmei Cao et al.
SCIENCE (2022)
Selective serotonin 5-HT2A receptor antagonists
Austen B. Casey et al.
BIOCHEMICAL PHARMACOLOGY (2022)
Effects of a psychedelic 5-HT2A receptor agonist on anxiety-related behavior and fear processing in mice
Blazej D. Pedzich et al.
NEUROPSYCHOPHARMACOLOGY (2022)
Role of 5-HT2A receptors in the effects of ayahuasca on ethanol self-administration using a two-bottle choice paradigm in male mice
Yasmim A. Serra et al.
PSYCHOPHARMACOLOGY (2022)
Bespoke library docking for 5-HT2A receptor agonists with antidepressant activity
Anat Levit Kaplan et al.
NATURE (2022)
The neural basis of psychedelic action
Alex C. Kwan et al.
NATURE NEUROSCIENCE (2022)
Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression
Guy M. Goodwin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects
Friederike Holze et al.
NEUROPSYCHOPHARMACOLOGY (2021)
Ketamine and Serotonergic Psychedelics: Common Mechanisms Underlying the Effects of Rapid-Acting Antidepressants
Bashkim Kadriu et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2021)
A non-hallucinogenic psychedelic analogue with therapeutic potential
Lindsay P. Cameron et al.
NATURE (2021)
Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms
Antonio Inserra et al.
PHARMACOLOGICAL REVIEWS (2021)
Lysergic acid diethylamide (LSD) promotes social behavior through mTORC1 in the excitatory neurotransmission
Danilo De Gregorio et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
A Dendrite-Focused Framework for Understanding the Actions of Ketamine and Psychedelics
Neil K. Savalia et al.
TRENDS IN NEUROSCIENCES (2021)
Prolonged epigenomic and synaptic plasticity alterations following single exposure to a psychedelic in mice
Mario de la Fuente Revenga et al.
CELL REPORTS (2021)
Brain-Derived Neurotrophic Factor Signaling in Depression and Antidepressant Action
Eero Castren et al.
BIOLOGICAL PSYCHIATRY (2021)
Psychedelic-inspired drug discovery using an engineered biosensor
Chunyang Dong et al.
CELL (2021)
The Hallucinogenic Serotonin2A Receptor Agonist, 2,5-Dimethoxy-4-Iodoamphetamine, Promotes cAMP Response Element Binding Protein-Dependent Gene Expression of Specific Plasticity-Associated Genes in the Rodent Neocortex
Lynette A. Desouza et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2021)
Psychedelics and Other Psychoplastogens for Treating Mental Illness
Maxemiliano V. Vargas et al.
FRONTIERS IN PSYCHIATRY (2021)
Trial of Psilocybin versus Escitalopram for Depression
Robin Carhart-Harris et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Harnessing psilocybin: antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT2R activation in mice
Natalie Hesselgrave et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder A Randomized Clinical Trial
Alan K. Davis et al.
JAMA PSYCHIATRY (2021)
Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo
Ling-Xiao Shao et al.
NEURON (2021)
Neuroplasticity as a convergent mechanism of ketamine and classical psychedelics
Lily R. Aleksandrova et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2021)
Transient Stimulation with Psychoplastogens Is Sufficient to Initiate Neuronal Growth
Calvin Ly et al.
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2021)
The Subjective Effects of Psychedelics May Not Be Necessary for Their Enduring Therapeutic Effects
David E. Olson
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2021)
The Subjective Effects of Psychedelics Are Necessary for Their Enduring Therapeutic Effects
David B. Yaden et al.
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2021)
Psychedelics, but Not Ketamine, Produce Persistent Antidepressant-like Effects in a Rodent Experimental System for the Study of Depression
Meghan Hibicke et al.
ACS CHEMICAL NEUROSCIENCE (2020)
Identification of Psychoplastogenic N,N-Dimethylaminoisotryptamine (isoDMT) Analogues through Structure-Activity Relationship Studies
Lee E. Dunlap et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species
Adam L. Halberstadt et al.
NEUROPHARMACOLOGY (2020)
Sustained rescue of prefrontal circuit dysfunction by antidepressant-induced spine formation
R. N. Moda-Sava et al.
SCIENCE (2019)
Psilocybin with psychological support for treatment-resistant depression: six-month follow-up
R. L. Carhart-Harris et al.
PSYCHOPHARMACOLOGY (2018)
Effects of N,N-Dimethyltryptamine on Rat Behaviors Relevant to Anxiety and Depression
Lindsay P. Cameron et al.
ACS CHEMICAL NEUROSCIENCE (2018)
Psychedelics Promote Structural and Functional Neural Plasticity
Calvin Ly et al.
CELL REPORTS (2018)
Preparation of Acute Brain Slices Using an Optimized N-Methyl-D-glucamine Protective Recovery Method
Jonathan T. Ting et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2018)
Changes in global and thalamic brain connectivity in LSD-induced altered states of consciousness are attributable to the 5-HT2A receptor
Katrin H. Preller et al.
ELIFE (2018)
Neuronal plasticity and neurotrophic factors in drug responses
E. Castren et al.
MOLECULAR PSYCHIATRY (2017)
Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants
Ronald S. Duman et al.
NATURE MEDICINE (2016)
Longitudinal Effects of Ketamine on Dendritic Architecture In Vivo in the Mouse Medial Frontal Cortex
Victoria Phoumthipphavong et al.
ENEURO (2016)
The effects of stress exposure on prefrontal cortex: Translating basic research into successful treatments for post-traumatic stress disorder
Amy F. T. Arnsten et al.
NEUROBIOLOGY OF STRESS (2015)
The failure of the antidepressant drug discovery process is systemic
Colin Hendrie et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2013)
Differential contributions of serotonin receptors to the behavioral effects of indoleamine hallucinogens in mice
Adam L. Halberstadt et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2011)
Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications
Rita Z. Goldstein et al.
NATURE REVIEWS NEUROSCIENCE (2011)
Psychedelic 5-Methoxy-N,N-Dimethyltryptamine: Metabolism, Pharmacokinetics, Drug Interactions, and Pharmacological Actions
Hong-Wu Shen et al.
CURRENT DRUG METABOLISM (2010)
Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later
R. R. Griffiths et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2008)
Hallucinogens recruit specific cortical 5-HT2A receptor-mediated signaling pathways to affect behavior
Javier Gonzalez-Maeso et al.
NEURON (2007)